IO Biotech, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VIVO CAPITAL, LLC | 02/13/2025 | 6.17 M | $5.68 M | 0.00% | 9.37% |
| NOVO HOLDINGS A/S | 02/14/2025 | 3.35 M | $3.09 M | 0.00% | 5.09% |
| PFM HEALTH SCIENCES, LP | 02/14/2025 | 2.34 M | $2.15 M | 0.00% | 3.55% |
| MARSHALL WACE, LLP | 02/13/2025 | 2.11 M | $1.94 M | 0.00% | 3.20% |
| BANK OF AMERICA CORP /DE/ | 02/14/2025 | 1.65 M | $1.52 M | 0.00% | 2.51% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 02/13/2025 | 864,197 | $795,061 | 0.00% | 1.31% |
| MORGAN STANLEY | 02/14/2025 | 859,175 | $790,441 | -60.98% | 1.30% |
| 02/14/2025 | 747,646 | $687,834 | 100.00% | 1.13% | |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 02/12/2025 | 442,196 | $406,820 | 100.00% | 0.67% |
| CITADEL ADVISORS LLC | 02/14/2025 | 270,504 | $248,864 | 100.00% | 0.41% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 192,670 | $177,256 | 0.00% | 0.29% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 174,000 | $160,080 | -12.84% | 0.26% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 118,800 | $109,296 | 22.47% | 0.18% |
| SECTORAL ASSET MANAGEMENT INC | 02/14/2025 | 75,000 | $69,000 | 100.00% | 0.11% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 60,650 | $54,000 | 0.00% | 0.09% |
| ROYAL BANK OF CANADA | 02/14/2025 | 60,000 | $55,000 | 100.00% | 0.09% |
| UBS GROUP AG | 02/14/2025 | 47,030 | $43,268 | -56.42% | 0.07% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 33,307 | $30,642 | 0.00% | 0.05% |
| VONTOBEL HOLDING LTD. | 01/30/2025 | 32,667 | $30,054 | 100.00% | 0.05% |
| XTX TOPCO LTD | 02/13/2025 | 28,040 | $25,797 | 100.00% | 0.04% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 03/17/2025 | 20,000 | $18,400 | 100.00% | 0.03% |
| 02/12/2025 | 16,000 | $14,720 | 100.00% | 0.02% | |
| HRT FINANCIAL LP | 02/14/2025 | 12,689 | $11,000 | -52.38% | 0.02% |
| TWO SIGMA SECURITIES, LLC | 02/14/2025 | 12,384 | $11,393 | 100.00% | 0.02% |
| 02/06/2025 | 130 | $120 | 100.00% | 0.00% | |
| CITIGROUP INC | 02/12/2025 | 5 | $5 | 100.00% | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/07/2025 | 0 | $0 | -100.00% | 0.00% |
| SAMSARA BIOCAPITAL, LLC | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
| LOGOS GLOBAL MANAGEMENT LP | 02/14/2025 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
IO Biotech, Inc. institutional Ownership - FAQ's
During the previous two years, 28 institutional investors and hedge funds held shares of IO Biotech, Inc.. The most heavily invested institutionals were:
Vivo Capital, LLC: 6.17 M
Novo Holdings A/S: 3.35 M
PFM Health Sciences, LP: 2.34 M
MARSHALL WACE, LLP: 2.11 M
BANK OF AMERICA CORP /DE/: 1.65 M
Pivotal bioVenture Partners Investment Advisor LLC: 864,197
29.89% of IO Biotech, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 18.93 M shares in the last 24 months. This purchase volume represents approximately $16.66 M in transactions.